Evidence map›Paper›PMID 39661061›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Enforced CARD11/MALT1 signaling in dendritic cells triggers hemophagocytic lymphohistiocytosis.

Sophie E Isay, Larsen Vornholz, Theresa Schnalzger, Tanja Groll, Thomas Magg, Patricia Loll, Gregor Weirich, Katja Steiger, Fabian Hauck, Jürgen Ruland

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sophie E IsayInstitute of Clinical Chemistry and Pathobiochemistry, School of Medicine and Health, Technical University of Munich, Munich 81675, Germany.ORCID 0000-0002-0495-2944
Larsen Vornholz *Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine and Health, Technical University of Munich, Munich 81675, Germany.ORCID 0000-0002-8054-5603
Theresa Schnalzger *Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine and Health, Technical University of Munich, Munich 81675, Germany.ORCID 0009-0002-1717-6486
Tanja GrollInstitute of Pathology, School of Medicine and Health, Technical University of Munich, Munich 81675, Germany.ORCID 0000-0002-9049-9145
Thomas MaggDepartment of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich 80337, Germany.ORCID 0000-0003-0158-7790
Patricia LollInstitute of Clinical Chemistry and Pathobiochemistry, School of Medicine and Health, Technical University of Munich, Munich 81675, Germany.
Gregor WeirichInstitute of Pathology, School of Medicine and Health, Technical University of Munich, Munich 81675, Germany.ORCID 0009-0001-2066-0925
Katja SteigerInstitute of Pathology, School of Medicine and Health, Technical University of Munich, Munich 81675, Germany.ORCID 0000-0002-7269-5433
Fabian HauckDepartment of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich 80337, Germany.ORCID 0000-0001-9644-2003
Jürgen RulandInstitute of Clinical Chemistry and Pathobiochemistry, School of Medicine and Health, Technical University of Munich, Munich 81675, Germany.ORCID 0000-0002-8381-3597

Funding

Bundesministerium für Bildung und Forschung (BMBF) 01GL2406BDeutsche Forschungsgemeinschaft (DFG) 210592381Deutsche Forschungsgemeinschaft (DFG) 369799452Deutsche Forschungsgemeinschaft (DFG) 395357507Deutsche Forschungsgemeinschaft (DFG) 435874434Deutsche Forschungsgemeinschaft (DFG) 452881907Deutsche Forschungsgemeinschaft (DFG) RU 695/12-1EC | ERC | HORIZON EUROPE European Research Council (ERC) 834154Leukemia and Lymphoma Society (LLS) 7029-23
6 · The paper itself

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening syndrome fueled by uncontrolled mononuclear phagocyte activity, yet the innate immune mechanisms driving HLH pathogenesis remain elusive. Germline gain-of-function (GOF) mutations in CARD11, a pivotal regulator of lymphocyte antigen receptor signaling, cause the lymphoproliferative disease B-cell expansion with NF-κB and T-cell anergy, which is frequently associated with HLH development. Given that CARD11 is physiologically expressed not only in lymphocytes but also in dendritic cells (DCs), we explored whether enforced CARD11 signaling in DCs contributes to immunopathology. We demonstrated that exclusive DC-intrinsic expression of CARD11-GOF in mice was sufficient to induce a lethal autoinflammatory syndrome that mimicked human HLH. Mechanistically, DC-intrinsic CARD11-GOF signaling triggered cell-autonomous inflammatory cytokine production via MALT1 paracaspase engagement. Genetic deletion of

Indexed as

CARD Signaling Adaptor ProteinsDendritic CellsLymphohistiocytosis, HemophagocyticMucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinSignal TransductionAnimalsGain of Function MutationGuanylate CyclaseHumansMiceMice, Inbred C57BLNF-kappa BCard11 protein, mouseCARD Signaling Adaptor ProteinsGuanylate CyclaseMalt1 protein, mouseMucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinNF-kappa BCARD11/MALT1 complexhemophagocytic lymphohistiocytosisimmunopathologyinborn errors of immunityinnate immune cell signaling

Identifiers

PMID39661061
PMCPMC11665875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.